Researchers from the OLLA-MED LLC center took part in the national congress dedicated to the diagnosis and treatment of respiratory diseases. During the congress, colleagues exchanged experience on a wide range of interdisciplinary problems and outlined ways for further cooperation.
Recruitment of patients who have had pulmonary tuberculosis into a clinical trial of the GamTBVac vaccine has begun to evaluate the effectiveness of the vaccine in preventing relapse. Remuneration for participation in the study is possible. Write to us 8 (993) 202 7840 (whatsapp).
The high professional level of our site was confirmed by an audit of the sponsor of one of the clinical studies conducted in our research center. We thank the auditors for their comments and suggestions, which we will definitely take into account in future work.
Our site will conduct a study of a new medicine for the treatment of bronchial asthma. The study will begin in November 2023, we invite patients for pre-selection!
